What is the current Pruritus Therapeutics Market size?

The Pruritus Therapeutics Market is projected to register a CAGR of 3.5% during the forecast period (2024-2029) Read More

Who are the key players in Pruritus Therapeutics Market?

Cara Therapeutics, EPI Health, LLC , Gladerma Laboratories, LP. , Sanofi SA and AbbVie Inc. are the major companies operating in the Pruritus Therapeutics Market. Read More

Which is the fastest growing region in Pruritus Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Pruritus Therapeutics Market?

In 2024, the North America accounts for the largest market share in Pruritus Therapeutics Market. Read More

What years does this Pruritus Therapeutics Market cover?

The report covers the Pruritus Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pruritus Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pruritus Therapeutic Market Size & Share Analysis - Industry Research Report

Pruritus Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Pruritus Therapeutics Market is Segmented by Product Type (Corticosteroid, Antihistamine, Local Anesthetic, Counterirritant, Immunosuppressant, Calcineurin Inhibitors, and Other Product Types), Disease Type (Atopic Dermatitis/Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-cell, and Other Disease Types) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Pruritus Therapeutic Industry Overview

The pruritus therapeutics market is fragmented due to the presence of many companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some key players are Actavis, AbbVie Inc., Astellas Pharma Inc., Cara Therapeutics, EPI Health LLC, Galderma Laboratories LP, Ocera Therapeutics Inc., and Pfizer Inc., Sanofi, Trevi Therapeutics, among others.